Company Long-Term Loans and Borrowings: Petros (PTPI)

Petros Pharmaceuticals (PTPI) focuses on developing men's wellness products, where the transition to over-the-counter status guarantees a steady cash flow. Simultaneously, the business is implementing digital patient services, optimizing therapy access through IT tools. The current debt load is 0.00. The asset's price trajectory is illustrated in the chart below.

This metric aggregates all liabilities with a maturity of over one year, reflecting the business's dependence on external financing. This metric determines long-term solvency and the risk of default amid changing interest rates. For Petros Pharmaceuticals (PTPI), debt capital can serve as leverage when transitioning drugs into the over-the-counter segment. An analysis of the organization's long-term financial debt confirms the effectiveness of this strategy. The stability of the chart indicates a resilient capital structure.